ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1390	National Cancer Institute	Html	en	Parathyroid Cancer Treatment (PDQ®)–Health Professional Version	Parathyroid cancer is very rare and is usually treated with surgery. Learn about the diagnosis, risk and genetic factors, staging, treatment, and management of parathyroid cancer in this expert-reviewed summary.	En bloc excision 0.580723 malignant parathyroid tumors 0.70882 benign parathyroid disease 0.742032 useful imaging adjuncts 0.564425 parathyroid cancer. 0.73642 Cervical lymph node 0.577512 Cancer Database series 0.580761 important new approach 0.566545 small tumor deposits 0.584869 parathyroid adenomas 0.693339 primary HPT 0.572268 parathyroid hormone 0.692017 patients 0.614406 frequent presenting complaint 0.563224 parathyroid carcinoma 0.974986 serum PTH concentrations 0.583231 trabecular growth patterns 0.562685 parathyroid cancer 0.749285 lymph nodes 0.628841 histologic cell types 0.567408 fewer patients 0.586809 Accessible distant metastases 0.572395 Serum PTH levels 0.584551 bloc resection 0.588765 overt skeletal involvement 0.564555	fairly indolent biology 0.562712 parathyroid adenoma 0.751441 low malignant potential 0.583743 parathyroid cancers 0.811741 local recurrence rate. 0.578566 adjuvant radiation therapy 0.564112 parathyroid carcinoma. 0.775435 recurrent laryngeal nerve 0.652868 hyperparathyroid bone disease 0.578044 parathyroid procedures 0.706298 cervical lymph nodes 0.58395 malignant tumor 0.574608 malignant parathyroid lesions. 0.713559 long-term local control 0.567886 dense fibrous trabeculae 0.563413 difficult-to-detect recurrent disease. 0.574206 parathyroid adenomas. 0.68234 primary tumor 0.565018 initial treatment goal 0.574628 median maximal diameter 0.575198 inferior parathyroid glands 0.778319 regional lymph nodes 0.602965 mixed cell types 0.564125 lymph node metastases 0.599404	CLICK HERE
1552	National Cancer Institute	Html	en	Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version	Childhood ALL is a type of cancer in which the bone marrow makes too many immature lymphocytes (a type of white blood cell). Here’s what you need to know about the risk factors, signs, tests to diagnose, and treatment of newly diagnosed and recurrent ALL in this expert-reviewed summary.	red blood cells 0.416225 cancer treatment 0.28631 chemotherapy 0.431874 treatments 0.247489 PDQ cancer information 0.278302 clinical trial search 0.311111 white blood cells 0.50903 children 0.34365 systemic chemotherapy 0.367092 higher doses 0.258659 mature blood cells 0.277223 Natural killer cells 0.232346 cancer information summary 0.242631 clinical trial 0.414978 stem cells 0.325781 stem cell transplant 0.490178 Lymphoblastic Leukemia Treatment 0.242048 blood cells 0.556083 intrathecal chemotherapy 0.289545 radiation therapy 0.442509 General information 0.218828 child 0.225345 treatment 0.73359 immature blood cells 0.228445 NCI-supported cancer 0.228604	cancer cells 0.364563 remission induction 0.378898 anticancer drugs 0.454791 specific cancer cells 0.244448 acute lymphocytic leukemia 0.228943 certain changes 0.25566 treatment clinical trials 0.245143 blood stem cells 0.262182 National Cancer Institute 0.245665 spinal cord 0.639894 ) cells. 0.915202 new treatment 0.267478 consolidation /intensification 0.293759 childhood 0.307766 clinical trials 0.932686 combination chemotherapy 0.358378 maintenance phases 0.246634 brain 0.275475 bone marrow 0.619374 Philadelphia chromosome 0.248781 cancer clinical trials 0.319159 acute lymphoblastic leukemia 0.930995 cancer 0.710977 information 0.309067	CLICK HERE
1714	National Cancer Institute	Html	en	Computed Tomography (CT) Scans and Cancer	A fact sheet that describes the CT scan procedure and technology and its uses in screening, diagnosis, and treatment.	CT imaging technology 0.569562 regular-dose CT scan 0.562007 lung cancer screening 0.54026 CT procedure 0.731231 newest CT scanners 0.587346 whole-body CT 0.57001 ct exams 0.558916 CT procedures 0.54984 lung cancer 0.592986 radiation dose 0.50377 health care providers 0.544231 multislice CT 0.569592 U.S. Food 0.504864 Lung Screening Trial 0.488364 single CT scan 0.559043 ct colonography 0.665422 colorectal cancer 0.498955 older CT techniques 0.588973 Tracking radiation exposure 0.48666 multiple CT scans 0.560065 standard CT 0.559346 National CT Colonography 0.621292 helical CT procedure 0.596247 low-dose CT scan 0.568401	average annual dose 0.483921 CT scanner manufacturers 0.553452 CT scans 0.582194 low-dose helical CT 0.69526 radiation risks 0.502098 Drug Administration 0.507156 radiation exposure 0.603574 modern CT machines 0.590707 American College 0.525134 original CT machines 0.590542 CT imaging 0.587843 National Lung Screening 0.489052 external-beam radiation therapy 0.487398 people 0.506505 natural background radiation 0.502791 CT 0.922359 radiation dose exposures 0.484749 radiation 0.608408 Unnecessary Radiation Exposure 0.486946 cancer risk 0.502536 cancer 0.609695 CT scanners 0.63294 multidetector CT scanners 0.588732 typical CT procedure 0.581742	CLICK HERE
1952	National Cancer Institute	Html	es	Tratamiento de las neoplasias de células plasmáticas (incluso mieloma múltiple) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de las neoplasias de células plasmáticas (incluso mieloma múltiple).	siguientes procedimientos 0.346148 células madre 0.945416 causa signos 0.305542 trasplante autógeno 0.329369 suficientes glóbulos 0.313511 siguientes cambios 0.312466 suficientes células 0.367406 células madre formadoras 0.329864 siguientes tipos 0.318034 siguientes fases 0.308352 rayos x 0.307538 causa hipercalcemia 0.310068 sumario tratamiento 0.33895 células anormales.ampliar aspiración 0.361154 causa problemas 0.309382 Nuevas combinaciones 0.305801 lesiones óseas 0.305545 National Cancer Institute 0.305225 siguientes riesgos 0.305748 células plasmáticas.Gammapatía 0.37332	Multiple Myeloma 0.338693 Instituto Nacional 0.318628 Plasma Cell Neoplasms 0.366703 PDQ Tratamiento 0.31456 presente sección 0.305256 beta-2 microglobulina 0.490964 Drugs Approved 0.337847 siguientes signos 0.334405 estudio regímenes 0.30494 Physician Data Query 0.319252 estadio iii 0.3425 proteína m 0.36173 inhibidor hdac 0.307303 siguientes enlaces 0.307028 células sanguíneas maduras 0.372655 células b 0.368037 siguientes pruebas 0.314313 siguientes sumarios 0.313298 Other Plasma Cell 0.367102	CLICK HERE
1963	National Cancer Institute	Html	es	Tratamiento del carcinoma de células de Merkel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del carcinoma de células de Merkel.	siguientes procedimientos 0.69003 estadio iv 0.713668 siguientes aspectos 0.637912 ganglio linfático centinela 0.981847 vía oral 0.618977 rayos x 0.627438 estadio ib 0.770198 Merkel causa efectos 0.682552 estadio ia 0.76846 escáner tep 0.628975 luz solar 0.628063 National Cancer Institute 0.617139 siguientes riesgos 0.613115	ganglios linfáticos.ampliar biopsia 0.728335 nota cambios 0.628407 Instituto Nacional 0.631866 estadio iiia 0.644166 PDQ Tratamiento 0.631004 estadio iia 0.644928 estadio iic 0.644457 Physician Data Query 0.665687 último panel 0.626069 siguientes características 0.637587 siguientes pruebas 0.688976 radiación ultravioleta 0.629465 siguientes estadios 0.630948	CLICK HERE
2040	National Cancer Institute	Html	es	Exámenes de detección del cáncer de piel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las pruebas que se utilizan para detectar sistemáticamente el cáncer de piel.	antecedentes familiares 0.452736 nevo atípico 0.361408 almacena agua 0.367337 lámparas solares 0.360685 PDQ Exámenes 0.39849 Physician Data Query 0.505569 mayores probabilidades 0.363001 radiación uv 0.621972 Estados Unidos 0.932757 simple vista 0.348992 prevención revisa 0.335498 Skin Cancer 0.36265	siguientes ejemplos 0.362131 luz solar 0.675106 información ayuda 0.338156 vitamina d 0.367339 Características genéticas 0.361581 National Cancer Institute 0.353374 siguientes riesgos 0.336165 piel melanoma 0.814223 radiación ultravioleta 0.507855 siguientes sumarios 0.40536 Instituto Nacional 0.399902	CLICK HERE
2077	National Cancer Institute	Html	es	Pruebas genéticas para síndromes hereditarios de cáncer	Trata de pruebas genéticas para riesgos heredados de cáncer; incluye tipos de pruebas, para quién son, explicación y confidencialidad de los resultados. Ofrece información de pruebas genéticas a domicilio o pruebas para el consumidor.	paciente grupos 0.426785 ningún efecto 0.430963 direct-to-consumer genetic testing 0.524243 Clinical Chemistry 0.427805 Privacy Rule 0.424134 Accountability Act 0.423749 gen mutante 0.448711 Clinical Laboratory Improvement 0.443406 copia mutante 0.438081 seguro médico 0.523691 valiosa oportunidad 0.42438 gen alteraciones 0.444199 Topol E 0.422575 profesionales genéticos 0.423689 información genética 0.694265 PubMed Abstract 0.469151 PMC Article 0.422751 pruebas genéticas caseras 0.933419 Clinical Oncology 0.46864 reliable or risky 0.440953 GWAS) por medio 0.422097 pequeña porción 0.422164 hijo hereda 0.4346 leyes gina 0.4236 determinada persona 0.471237	profesional conocedor 0.425068 negativo carente 0.503682 Health Information Portability 0.441872 cuidado preventivo 0.422328 Clinical Oncology Policy 0.44516 ASHG statement 0.425726 genomic testing 0.424164 conocida mutación 0.495717 falsa seguridad 0.422355 Genética Humana 0.494712 Javitt G 0.4224 Federal Trade Commission 0.438077 Human Genetics 0.422666 cabo pruebas 0.510628 antecedentes familiares 0.466262 pruebas quizás 0.52233 posibles alternativas 0.424779 complicada decisión 0.427954 estudios por asociación 0.422415 profesional genético 0.434126 negativo falso 0.497922 hijos hombres 0.425049 llama portadores 0.430487 llamadas polimorfismos 0.425347	CLICK HERE
3416	National Cancer Institute	Html	en	The NCTN Budget	The overall NCTN budget for these awards is $151 million. This amount is the same as the total budget provided to the Cooperative Groups for awards in each of fiscal years 2012 and 2013, despite the substantial reductions in the NCI budget that resulted from sequestration starting in 2013. What has changed, however, is the distribution of funds to the various components of the NCTN, as compared with the components of the former Cooperative Group program.	future clinical trials 0.56818 large numbers 0.48775 medicine clinical trials 0.552592 Medidata Rave® 0.477945 smaller interventional components 0.50085 NCI budget 0.524673 complex analytic algorithms 0.469817 important trials 0.467438 clinical trial functions 0.476947 additional annual support 0.477353 entail new expenses 0.505576 clinical trials 0.953052 funding supplements 0.459855 one-stop online access 0.458554 Group Operations Center 0.520009 normal genetic variants 0.470288 overall NCTN budget 0.558633 patients 0.498402 separate funding stream 0.466002 Network Group Operations 0.667965 Investigational New Drug 0.483971 NCTN treatment trials 0.641251 fresh biopsy samples 0.473644 Studies Funding Program 0.482252 Group Operations Centers 0.508084	NCI 0.653194 patient selection 0.483879 U.S. adult groups 0.497468 appropriate molecular profile 0.474342 Cooperative Groups 0.505409 RNA sequencing methods 0.473512 Cancer Trials Support 0.534613 NCTN trials 0.601972 actual interventional study 0.491932 specific molecular characteristics 0.475625 fewer active trials 0.544364 rapid turnaround times 0.471955 NCTN groups 0.757227 NCTN Group Operations 0.525903 separate NCI award 0.549229 interventional trials 0.493629 newly consolidated groups 0.490605 Cooperative Group program 0.522132 larger therapeutic effects 0.463659 correlative science studies 0.465254 common data management 0.623125 new trials 0.510263 group trials 0.461981 previous trials 0.464198	CLICK HERE
3454	National Cancer Institute	Html	es	Grados de comprobación científica de los estudios de terapias integrales, alternativas y complementarias en seres humanos con cáncer (PDQ®)–Versión para profesionales de salud	Información acerca de cómo evaluar la solidez de los datos probatorios obtenidos de los estudios de investigación sobre terapias integrales, alternativas y complementarias en seres humanos con cáncer.	Visuals Online 0.6561 grupo control 0.658003 Physician Data Query 0.707803 distintos tipos 0.676327 mejores casos— 0.670195 valoración indirectos 0.860816 tratamiento versus muerte 0.748944	National Cancer Institute 0.697449 personas ayuda 0.673043 siguientes riesgos 0.659857 mejores casos 0.807578 versus muerte 0.798627 Instituto Nacional 0.960893	CLICK HERE
17193	National Cancer Institute	Html	en	U.S. - China Program for Biomedical Research Cooperation	U.S. - China Program for Biomedical Research Cooperation Preliminary Program Review.	Office 0.440565 OAR 0.472714 Allergy 0.446266 scientific accomplishments 0.62865 projects 0.51324 Additional outcomes 0.632018 National Natural Science 0.9169 Mental Health 0.663295 Chinese scientists 0.664312 translational biomedical research. 0.976759 National Cancer Institute 0.919012 Foundation 0.442112 preliminary evaluation 0.675445 US-China 0.436834 results 0.435543 National Institute 0.932171 National Institutes 0.697264 common successes 0.636736 Administrative Supplements 0.654736 Stroke 0.440417 Collaborative Biomedical Research 0.935063	Global Health 0.637782 NSFC 0.441999 future collaborative programs 0.854353 impacts 0.442029 countries 0.439905 NIAID 0.482086 NIH 0.458074 international collaboration 0.640713 joint initiative 0.663479 Neurological Disorders 0.660677 NIMH 0.468305 Researchers 0.441544 U.S.-China Program 0.677605 report 0.435896 Infectious Diseases 0.665033 scientifically meritorious investigations 0.921915 Biomedical Research Cooperation 0.865108 Preliminary Program Review 0.859879 AIDS Research 0.660227 R01 mechanisms 0.711872	CLICK HERE